Browse Pet Safety Reports
1,332,683 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 1,332,683 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 1,332,683 FDA veterinary adverse event reports.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Mar 15, 2026 | Horse | Quarter Horse | Ceftiofur Crystalline Free Acid | Medication error NOS; Colic; Hind limb ataxia; Congested mucous membrane; Rec... | Outcome Unknown |
| Mar 15, 2026 | Horse | Appaloosa | Pentosan Polysulfate Sodium | Lethargy (see also Central nervous system depression in Neurological); Inject... | Ongoing |
| Mar 15, 2026 | Dog | Dog (unknown) | Ilunocitinib | Lethargy (see also Central nervous system depression in Neurological) | Recovered/Normal |
| Mar 15, 2026 | Dog | Bulldog - American | Ilunocitinib | Elevated serum alkaline phosphatase (ALP); Not eating; Ataxia; Hepatopathy; R... | Ongoing |
| Mar 15, 2026 | Dog | Crossbred Canine/dog | Bedinvetmab | Limb non-weight bearing; Abnormal tail posture; Lethargy (see also Central ne... | Outcome Unknown |
| Mar 15, 2026 | Cat | Cat (unknown) | Selamectin;Sarolaner | Hiding; Vocalisation; Panting | Outcome Unknown |
| Mar 15, 2026 | Dog | Dog (unknown) | Oclacitinib Maleate | Skin lump; Neoplasia NOS | Outcome Unknown |
| Mar 15, 2026 | Dog | Crossbred Canine/dog, Sheph... | Fluralaner Powder For Inj Susp | Emesis (multiple); Lethargy (see also Central nervous system depression in Ne... | Ongoing |
| Mar 15, 2026 | Dog | Bichon Frise, Shih Tzu | Grapiprant | Accidental exposure; Emesis (multiple) | Recovered/Normal |
| Mar 15, 2026 | Dog | Bichon Frise | Grapiprant | Accidental exposure; Emesis (multiple) | Outcome Unknown |
| Mar 15, 2026 | Dog | Terrier - Boston | Pyrantel Pamoate;Sarolaner | Behavioural disorder NOS; Crying; Staring; Trembling; Lethargy (see also Cent... | Outcome Unknown |
| Mar 14, 2026 | Dog | Retriever - Labrador | Imidacloprid; Moxidectin | Lack of efficacy (endoparasite) - roundworm NOS | Outcome Unknown |
| Mar 14, 2026 | - | Unknown | Praziquantel | UNPALATABLE; Product defect, product difficult to use/handle (see also 'Drug ... | - |
| Mar 14, 2026 | Cat | Domestic Shorthair | Molidustat Sodium | Lack of efficacy - NOS | Outcome Unknown |
| Mar 14, 2026 | Dog | Retriever - Labrador | Bedinvetmab | Limping; Limb weakness; Cough; Neurological signs NOS; Wobbliness; Collapse N... | Ongoing |
| Mar 14, 2026 | Dog | Retriever - Labrador | Ivermectin; Pyrantel | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Mar 14, 2026 | Dog | Shepherd Dog - Australian | Afoxolaner 75Mg / Moxidectin 360Mcg /... | Lack of efficacy (endoparasite) - roundworm NOS | Ongoing |
| Mar 14, 2026 | Dog | Retriever - Labrador | Moxidectin | Injection site lump | Ongoing |
| Mar 14, 2026 | Dog | Crossbred Canine/dog | Bedinvetmab | Cough; Gagging; Dysphonia; Pulmonary oedema; Congestive heart failure; Medica... | Ongoing |
| Mar 14, 2026 | Cat | Domestic Shorthair | Bexagliflozin | Hyperglycaemia; Ketosis | Ongoing |
| Mar 14, 2026 | Dog | Shepherd Dog - Belgian Mali... | Moxidectin | Hives (see also Skin); Facial swelling (see also Skin); Hypersensitivity reac... | Ongoing |
| Mar 14, 2026 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Elevated alanine aminotransferase (ALT); Ketosis; Decreased appetite | Ongoing |
| Mar 14, 2026 | Cat | Domestic Shorthair | Selamectin;Sarolaner | Application site hair loss; Application site scab; Skin and tissue infection NOS | Ongoing |
| Mar 14, 2026 | Dog | Hound (unspecified), Dog (u... | Pyrantel Pamoate;Sarolaner | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Mar 14, 2026 | Dog | Retriever - Labrador | Fluralaner Powder For Inj Susp | Lethargy (see also Central nervous system depression in Neurological); Abnorm... | Outcome Unknown |
| Mar 14, 2026 | Dog | Siberian Husky | Pyrantel Pamoate;Sarolaner | Lack of efficacy (endoparasite) - heartworm; Intentional misuse | Ongoing |
| Mar 14, 2026 | Dog | Chihuahua, Dog (unknown) | Pyrantel Pamoate;Sarolaner | Lack of efficacy (bacteria) - Borrelia; Lack of efficacy (bacteria) - Anaplas... | Ongoing |
| Mar 14, 2026 | Dog | Maltese, Dog (unknown) | Pyrantel Pamoate;Sarolaner | Lack of efficacy (bacteria) - Borrelia | Ongoing |
| Mar 14, 2026 | Dog | Retriever - Labrador | Pyrantel Pamoate;Sarolaner | Lack of efficacy (endoparasite) - roundworm NOS | Ongoing |
| Mar 14, 2026 | Dog | Coonhound - Black and Tan | Gentamicin Sulfate; Hydrocortisone Ac... | Loss of hearing | Outcome Unknown |
| Mar 14, 2026 | Dog | Shih Tzu | Fluralaner Powder For Inj Susp | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Mar 14, 2026 | Cat | Ragdoll | Nitenpyram | Panting; Hyperactivity; Expired drug administered; Tongue protrusion | Outcome Unknown |
| Mar 14, 2026 | Dog | Shepherd Dog - German, Dog ... | Phenylpropropanolamine Hcl | Slow heart rate; Wobbliness; Vomiting; Eye disorder NOS (for Photophobia see ... | Ongoing |
| Mar 14, 2026 | Dog | Shepherd (unspecified), Dog... | Pyrantel Pamoate;Sarolaner | Lack of efficacy (bacteria) - Borrelia; Lack of efficacy (bacteria) - Ehrlich... | Ongoing |
| Mar 14, 2026 | Dog | Crossbred Canine/dog | Fluralaner Powder For Inj Susp | Seizure NOS; Head shake - behavioural disorder; Pawing; Hypersalivation; Symp... | Ongoing |
| Mar 14, 2026 | Dog | Crossbred Canine/dog | Bedinvetmab | Elevated alanine aminotransferase (ALT); Elevated serum alkaline phosphatase ... | Outcome Unknown |
| Mar 14, 2026 | Dog | Rottweiler | Fluralaner 13.64% 12-Week Chew | Diarrhoea | Ongoing |
| Mar 14, 2026 | Dog | Crossbred Canine/dog, Retri... | Fluralaner Powder For Inj Susp | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Mar 14, 2026 | Dog | Shepherd Dog - Australian, ... | Pyrantel Pamoate;Sarolaner | Lack of efficacy (bacteria) - Anaplasma; Medication error NOS | Ongoing |
| Mar 14, 2026 | Dog | Terrier (unspecified), Dog ... | Carprofen | Vomiting; Wheezing; Drooling; Cough; Tachypnoea; Lethargy (see also Central n... | Recovered/Normal |
| Mar 14, 2026 | Dog | Bulldog - French | Pyrantel Pamoate;Sarolaner | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Mar 14, 2026 | Dog | Corgi (unspecified) | Pyrantel Pamoate;Sarolaner | Lack of efficacy (endoparasite) - hookworm | Ongoing |
| Mar 14, 2026 | Dog | Pit Bull | Gentamicin Sulfate; Hydrocortisone Ac... | Loss of hearing | Ongoing |
| Mar 14, 2026 | Dog | Chihuahua | Moxidectin | Seizure NOS | Recovered/Normal |
| Mar 14, 2026 | Cat | Domestic Shorthair | Fluralaner/Moxidectin Spot-On | Lack of efficacy (endoparasite) - roundworm NOS | Ongoing |
| Mar 14, 2026 | Dog | Spaniel - Cocker English | Bedinvetmab | Inappropriate urination; Weakness; Inappetence | Recovered/Normal |
| Mar 14, 2026 | Dog | Shepherd Dog - German | Moxidectin | Lack of efficacy (endoparasite) - hookworm | Ongoing |
| Mar 14, 2026 | Dog | Chihuahua | Pimobendan | Abnormal breathing; Heart pounding; Head tilt - neurological disorder (see al... | Recovered/Normal |
| Mar 14, 2026 | Dog | Crossbred Canine/dog | Moxidectin | Vomiting; Unsteady gait | Ongoing |
| Mar 14, 2026 | Dog | Retriever - Labrador, Dog (... | Lotilaner,Moxidectin,Praziquantel,Pyr... | Diarrhoea | Outcome Unknown |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.